Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 2,857 shares at $38.69 ($111K) on 2026-07-23, disclosed to the SEC on 2026-07-24.
Open-market sale of $111k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |
| IMVT | SELL | 2026-01-23 | $51K | — | Filing → |